PlainRecalls
FDA Drug Low Class III Terminated

Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50

Reported: June 1, 2022 Initiated: January 15, 2021 #D-1123-2022

Product Description

Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50

Reason for Recall

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Details

Units Affected
13 bottles
Distribution
1 physician in Alpharetta, GA
Location
Albuquerque, NM

Frequently Asked Questions

What product was recalled?
Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50. Recalled by Calvin Scott & Company, Inc.. Units affected: 13 bottles.
Why was this product recalled?
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 1, 2022. Severity: Low. Recall number: D-1123-2022.